Dr. James D. Kerner, M.D., PHD
Dermatology (Dermatology Physician)
141 N Roadrunner Pkwy Ste 228
Las Cruces, NM 88011
Who else practices at this address →
Doña Ana County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Washington University School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 2,717
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Washington University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
NM license MD2005-0865
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Medical Center Las Cruces, NM
- Mountain View Regional Medical Center Las Cruces, NM
Medical groups
- Epiphany Dermatology of New Mexico, LLC (32 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,717
- Services billed
- 15,388
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 4,011 | 875 |
| Established patient office or other outpatient visit, 20-29 minutes | 2,647 | 1,884 |
| Biopsy of related skin growth, first growth | 1,667 | 1,310 |
| Destruction of precancer skin growth, 1 growth | 1,397 | 1,113 |
| Pathology examination of tissue using a microscope, intermediate complexity | 952 | 464 |
| Biopsy of related skin growth, each additional growth | 819 | 515 |
| Established patient office or other outpatient visit, 30-39 minutes | 387 | 287 |
| Destruction of skin growth, 1-14 growths | 386 | 344 |
| New patient office or other outpatient visit, 30-44 minutes | 318 | 318 |
| Established patient office or other outpatient visit, 10-19 minutes | 289 | 266 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 33 payments worth $572 in total to this clinician.
| Janssen Biotech, Inc. | $164 |
|---|---|
| AbbVie Inc. | $94.23 |
| Amgen Inc. | $94.12 |
| Genzyme Corporation | $68.79 |
| Organon LLC | $35.14 |
| Novartis Pharmaceuticals Corporation | $34.55 |
| E.r. Squibb & Sons, L.l.c. | $29.51 |
| UCB, Inc. | $18.57 |
| Food and Beverage | $487 |
|---|---|
| Education | $84.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 28, 2025 | Education TREMFYA · Immunology · in-kind | $84.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.